⌘K

Home/Filings/4/0001181431-11-061516

4//SEC Filing

Biggar Stephen R 4

Accession 0001181431-11-061516

CIK 0000911326other

View on SEC.gov Company Profile

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 3:58 PM ET

Size

5.2 KB

Accession

0001181431-11-061516

Insider Transaction Report

Form 4

Period: 2011-12-20

SYNAGEVA BIOPHARMA CORPGEVA

Biggar Stephen R

Director

Transactions

Award
Stock Option (Right to Buy)
2011-12-20−15,000→ 15,000 total
Exercise: $23.00Exp: 2021-12-19→ Common Stock (15,000 underlying)

Footnotes (1)

[F1]1/36 of the shares subject to this option vest and become exercisable on December 2, 2011 and monthly thereafter.

Documents

1 file

4
rrd328650.xmlPrimary
BIGGAR 122011 FORM 4

Issuer

SYNAGEVA BIOPHARMA CORP

CIK 0000911326

Entity typeother

Related Parties

1

filerCIK 0001340380

Filing Metadata

Form type: 4
Filed: Dec 20, 7:00 PM ET
Accepted: Dec 21, 3:58 PM ET
Size: 5.2 KB

View on SEC.gov